Free Design Audit Available - Click Here for Details

FDA clears 5008X hemodialysis system from Fresenius Medical Care

Fresenius Medical Care announced today that it received FDA clearance for its 5008X hemodialysis system.

The company said this marks a step toward bringing a new standard of care in dialysis therapy to the U.S. Bad Homburg, Germany-based Fresenius can now begin U.S.-based clinical evaluations and user studies ahead of a broad launch in 2025.

Fresenius’ 5008X system offers industry-leading, high-volume hemodiafiltration dialysis therapy. Along with the companion FX CorAL dialyzer, it combines the latest device engineering and cutting-edge membrane technologies. The company says these technologies make high-volume hemodiafiltration possible.

Sign up for Blog Updates